![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
FDA Approves Daiichi Sankyos TURALIO pexidartinib for the Treatment of Select Patients with TGCT...
Daiichi Sankyo Company, Limited announced that the U.S. FDA approved TURALIO™ (pexidartinib) as the first...
LexaGene Approved by CDC and FDA Antibiotic Resistance Isolate Bank to Receive Samples
LexaGene Holdings, Inc, a biotechnology company that develops genetic analyzers for pathogen detection and other...
Drug-Eluting Devices: Delivering on Drug Delivery’s Combined Potential
Implantable drug-eluting devices (DEDs) have come a long way since 1938, when Finland approved a...
A Powerful Pairing: Academia-Industry Collaborations for Pharmaceutical Innovation
Innovation is unarguably the essence of pharmaceutical discovery and development. Industry and academia have been...
New state of the art cleanroom completed by WHP for ADC bio
Production of new anti-cancer drugs at ADC Bio’s North Wales manufacturing plant has been boosted...
Pathogen engineered to self destruct underlies cancer vaccine platform
A team of investigators has developed a cancer vaccine technology using live, attenuated pathogens as...
Artificial DNA can control release of active ingredients from drugs
A drug with three active ingredients that are released in sequence at specific times: Thanks...
Oncimmune and Biodesix Form Strategic Partnership to Unlock Full Potential of EarlyCDT Lung in...
Oncimmune Holdings plc ,a leading global immunodiagnostics group announces it has entered into an exclusive...
Priorclave Launches New Autoclave Controller
All laboratory autoclaves and research sterilisers leaving the Priorclave design and manufacturing centre in the...
Artificial enzyme: Protein designed entirely from scratch functions in cells as a life-sustaining catalyst
A dawning field of research, artificial biology, is working toward creating a genuinely new organism....